Community Academic Profiles–

Ross Shachter

Back to Profile

Publication Details

  • Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.

    Rupnow MF, Chang AH, Shachter RD, Owens DK, Parsonnet J. J Infect Dis. 2009; 200 (8): 1311-7

    Helicobacter pylori vaccines are under development to prevent infection. We quantified the cost-effectiveness of such a vaccine in the United States, using a dynamic transmission model.

    PubMedID: 19751153

Stanford Medicine Resources:

Footer Links: